Literature DB >> 23820730

Proteomic analysis of the SH2 domain-containing leukocyte protein of 76 kDa (SLP76) interactome in resting and activated primary mast cells [corrected].

Yacine Bounab1, Anne-Marie- Hesse, Bruno Iannascoli, Luca Grieco, Yohann Couté, Anna Niarakis, Romain Roncagalli, Eunkyung Lie, Kong-Peng Lam, Caroline Demangel, Denis Thieffry, Jérôme Garin, Bernard Malissen, Marc Daëron.   

Abstract

We report the first proteomic analysis of the SLP76 interactome in resting and activated primary mouse mast cells. This was made possible by a novel genetic approach used for the first time here. It consists in generating knock-in mice that express signaling molecules bearing a C-terminal tag that has a high affinity for a streptavidin analog. Tagged molecules can be used as molecular baits to affinity-purify the molecular complex in which they are engaged, which can then be studied by mass spectrometry. We examined first SLP76 because, although this cytosolic adapter is critical for both T cell and mast cell activation, its role is well known in T cells but not in mast cells. Tagged SLP76 was expressed in physiological amounts and fully functional in mast cells. We unexpectedly found that SLP76 is exquisitely sensitive to mast cell granular proteases, that Zn(2+)-dependent metalloproteases are especially abundant in mast cells and that they were responsible for SLP76 degradation. Adding a Zn(2+) chelator fully protected SLP76 in mast cell lysates, thereby enabling an efficient affinity-purification of this adapter with its partners. Label-free quantitative mass spectrometry analysis of affinity-purified SLP76 interactomes uncovered both partners already described in T cells and novel partners seen in mast cells only. Noticeably, molecules inducibly recruited in both cell types primarily concur to activation signals, whereas molecules recruited in activated mast cells only are mostly associated with inhibition signals. The transmembrane adapter LAT2, and the serine/threonine kinase with an exchange factor activity Bcr were the most recruited molecules. Biochemical and functional validations established the unexpected finding that Bcr is recruited by SLP76 and positively regulates antigen-induced mast cell activation. Knock-in mice expressing tagged molecules with a normal tissue distribution and expression therefore provide potent novel tools to investigate signalosomes and to uncover novel signaling molecules in mast cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820730      PMCID: PMC3790297          DOI: 10.1074/mcp.M112.025908

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  51 in total

1.  Complete structure and expression in transfected cells of high affinity IgE receptor.

Authors:  U Blank; C Ra; L Miller; K White; H Metzger; J P Kinet
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

2.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

Authors:  Jürgen Cox; Matthias Mann
Journal:  Nat Biotechnol       Date:  2008-11-30       Impact factor: 54.908

Review 3.  Mapping multiprotein complexes by affinity purification and mass spectrometry.

Authors:  Mark O Collins; Jyoti S Choudhary
Journal:  Curr Opin Biotechnol       Date:  2008-07-16       Impact factor: 9.740

4.  Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

Authors:  Viveka Mayya; Deborah H Lundgren; Sun-Il Hwang; Karim Rezaul; Linfeng Wu; Jimmy K Eng; Vladimir Rodionov; David K Han
Journal:  Sci Signal       Date:  2009-08-18       Impact factor: 8.192

5.  Antigen receptor tail clue.

Authors:  M Reth
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

6.  Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells.

Authors:  J K Jackman; D G Motto; Q Sun; M Tanemoto; C W Turck; G A Peltz; G A Koretzky; P R Findell
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

7.  The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation.

Authors:  S Sahay; N L Pannucci; G M Mahon; P L Rodriguez; N J Megjugorac; E V Kostenko; H L Ozer; I P Whitehead
Journal:  Oncogene       Date:  2007-10-08       Impact factor: 9.867

8.  Quantitative time-resolved phosphoproteomic analysis of mast cell signaling.

Authors:  Lulu Cao; Kebing Yu; Cindy Banh; Vinh Nguyen; Anna Ritz; Benjamin J Raphael; Yuko Kawakami; Toshiaki Kawakami; Arthur R Salomon
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

9.  Agouti C57BL/6N embryonic stem cells for mouse genetic resources.

Authors:  Stephen J Pettitt; Qi Liang; Xin Y Rairdan; Jennifer L Moran; Haydn M Prosser; David R Beier; Kent C Lloyd; Allan Bradley; William C Skarnes
Journal:  Nat Methods       Date:  2009-06-14       Impact factor: 28.547

10.  Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL.

Authors:  Petra Volná; Pavel Lebduska; Lubica Dráberová; Sárka Símová; Petr Heneberg; Michael Boubelík; Viktor Bugajev; Bernard Malissen; Bridget S Wilson; Václav Horejsí; Marie Malissen; Petr Dráber
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

View more
  3 in total

1.  Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation.

Authors:  Nicholas J Shubin; Veronika A Glukhova; Morgan Clauson; Phuong Truong; Magnus Abrink; Gunnar Pejler; Nathan J White; Gail H Deutsch; Stephen R Reeves; Tomas Vaisar; Richard G James; Adrian M Piliponsky
Journal:  J Allergy Clin Immunol       Date:  2016-05-13       Impact factor: 10.793

2.  Automated inference of Boolean models from molecular interaction maps using CaSQ.

Authors:  Sara Sadat Aghamiri; Vidisha Singh; Aurélien Naldi; Tomáš Helikar; Sylvain Soliman; Anna Niarakis
Journal:  Bioinformatics       Date:  2020-08-15       Impact factor: 6.937

3.  A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells.

Authors:  Zijun Wang; Mou Peng
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.